🔗 Share this article

An underground economy for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Treatment Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of rapid UK delivery. Vendors promote the drug there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Worries

However, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the UK is worrisome and could lead to users injecting products of unknown origin.

Some experts stated the popularity for the experimental drug could be connected to the rising cost of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or supplied for human use under the British medical regulations.

Some influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, risking fines, legal action or imprisonment.

Platform Response and Material Removal

According to TikTok, the service has taken down problematic content and banned related hashtags and search suggestions. The organization said it was committed to keeping the platform secure and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Investigations also discovered groups with up to nine thousand members marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, filled with images of weight loss, glowing reviews and detailed guides for mixing or administering at home.

After moments of joining one community, a seller shared WhatsApp details, where the majority of purchases occur. The vendor sent an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Item Details and Pricing

Inside these groups, messages show black plastic parcels with postal service labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how long a pen should last, vendors give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service said it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they cannot confirm. Even if the science behind retatrutide is sound, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has already encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational product not yet approved … may subject users to possibly serious medical dangers”.